welbournes

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (27/02/2025) announced the following list of price concessions for February 2025: Please note: Following a mid-month price increase reported by pharmacy owners, Community Pharmacy England has secured an [...]

The post February 2025 Price Concessions 3rd Update appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (18/02/2025) announced the following list of price concessions for February 2025: Drug Pack size Price concession Bimatoprost 300micrograms/ml / Timolol 5mg/ml eye drops 3 £8.83 Calcipotriol 0.005% / [...]

The post February 2025 Price Concessions 2nd Update appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (14/02/2025) announced the following initial list of price concessions for February 2025: Drug  Pack size Price concession Acamprosate 333mg gastro-resistant tablets 168 £21.65 Alendronic acid 70mg tablets* 4 [...]

The post February Price Concessions 1st Update appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Quetiapine 50mg, 150mg, 200mg, 300mg and 400mg modified-release tablets MSN/2025/006 Tier 2 medium impact Date of issue: 10th February 2025 There are supply constraints affecting quetiapine 50mg, 150mg, 200mg, 300mg and 400mg modified-release tablets (see supply summary table in Supporting information). [...]

The post Medicine Supply Notification: Quetiapine 50mg, 150mg, 200mg, 300mg and 400mg modified-release tablets appeared first on Community Pharmacy England.

Drug alert number: EL (25)A/05 Date issued: 5 February 2025 CNX Therapeutics is recalling the batches listed in this notification as a precautionary measure due to a small number of packs that contain an additional tablet of Nitrofurantoin. The registered product is a capsule containing powder and two yellow tablets. Nitrofurantoin 100 mg Prolonged-Release capsules [...]

The post MHRA Class 2 Medicines recall: Nitrofurantoin 100 mg Prolonged-Release capsules (CNX Therapeutics) appeared first on Community Pharmacy England.